Q3 2023
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| IKNA | New | Ikena Oncology, Inc. | $116,187 | – | 26,833 | – | 0.26% | – |
| Exit | DICE Therapeutics Inc. | $0 | – | -268,346 | – | -21.26% | – |
Q2 2023
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| CNTA | New | Centessa Pharmaceuticals plcsponsored ads | $18,183,837 | – | 2,937,615 | – | 31.01% | – |
| New | DICE Therapeutics Inc. | $12,467,355 | – | 268,346 | – | 21.26% | – | |
| AVTE | New | Aerovate Therapeutics Inc. | $10,354,518 | – | 603,762 | – | 17.66% | – |
| CYT | New | Cyteir Therapeutics, Inc. | $6,394,887 | – | 2,459,572 | – | 10.91% | – |
| PMVP | New | PMV Pharmaceuticals, Inc. | $6,192,592 | – | 989,232 | – | 10.56% | – |
| VOR | New | Vor Biopharma Inc. | $1,157,866 | – | 374,714 | – | 1.98% | – |
| GRPH | New | Graphite Bio | $1,056,401 | – | 406,308 | – | 1.80% | – |
| SELB | New | Selecta Biosciences, Inc. | $966,048 | – | 862,543 | – | 1.65% | – |
| New | eFFECTOR Therapeutics, Inc. | $851,534 | – | 1,025,697 | – | 1.45% | – | |
| DTIL | New | Precision BioSciences, Inc. | $591,178 | – | 1,123,913 | – | 1.01% | – |
| SPRO | New | Spero Therapeutics, Inc. | $361,152 | – | 249,070 | – | 0.62% | – |
| FIXX | New | Homology Medicines, Inc. | $56,640 | – | 64,000 | – | 0.10% | – |
Q4 2022
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| FIXX | Exit | Homology Medicines, Inc. | $0 | – | -64,000 | – | -0.16% | – |
| SPRO | Exit | Spero Therapeutics, Inc. | $0 | – | -249,070 | – | -0.78% | – |
| Exit | eFFECTOR Therapeutics, Inc. | $0 | – | -1,025,697 | – | -0.91% | – | |
| LABP | Exit | Landos Biopharma, Inc. | $0 | – | -1,237,667 | – | -1.25% | – |
| GRPH | Exit | Graphite Bio | $0 | – | -406,308 | – | -2.01% | – |
| Exit | Evolv Technologies Holdings, Inc. | $0 | – | -652,475 | – | -2.15% | – | |
| SELB | Exit | Selecta Biosciences, Inc. | $0 | – | -862,543 | – | -2.20% | – |
| DTIL | Exit | Precision BioSciences, Inc. | $0 | – | -1,123,913 | – | -2.28% | – |
| VOR | Exit | Vor Biopharma Inc. | $0 | – | -374,714 | – | -2.32% | – |
| CYT | Exit | Cyteir Therapeutics, Inc. | $0 | – | -2,469,572 | – | -7.38% | – |
| Exit | ionQ, Inc. | $0 | – | -1,177,597 | – | -9.30% | – | |
| AVTE | Exit | Aerovate Therapeutics Inc. | $0 | – | -603,762 | – | -15.59% | – |
| Exit | DICE Therapeutics Inc. | $0 | – | -536,693 | – | -16.95% | – | |
| PMVP | Exit | PMV Pharmaceuticals, Inc. | $0 | – | -989,232 | – | -18.33% | – |
| CNTA | Exit | Centessa Pharmaceuticals plcsponsored ads | $0 | – | -2,937,615 | – | -18.39% | – |
Q3 2022
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| Sell | ionQ, Inc. | $5,970,000 | -1.1% | 1,177,597 | -14.5% | 9.30% | +12.0% | |
| CYT | Sell | Cyteir Therapeutics, Inc. | $4,742,000 | -35.9% | 2,469,572 | -0.2% | 7.38% | -27.5% |
| Sell | Evolv Technologies Holdings, Inc. | $1,383,000 | -67.1% | 652,475 | -58.8% | 2.15% | -62.8% | |
| LABP | Sell | Landos Biopharma, Inc. | $804,000 | -31.5% | 1,237,667 | -23.3% | 1.25% | -22.5% |
Q2 2022
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| CNTA | New | Centessa Pharmaceuticals plcsponsored ads | $14,306,000 | – | 2,937,615 | – | 19.69% | – |
| PMVP | New | PMV Pharmaceuticals, Inc. | $14,097,000 | – | 989,232 | – | 19.40% | – |
| AVTE | New | Aerovate Therapeutics Inc. | $9,437,000 | – | 603,762 | – | 12.99% | – |
| New | DICE Therapeutics Inc. | $8,329,000 | – | 536,693 | – | 11.46% | – | |
| CYT | New | Cyteir Therapeutics, Inc. | $7,399,000 | – | 2,474,572 | – | 10.18% | – |
| New | ionQ, Inc. | $6,034,000 | – | 1,377,597 | – | 8.30% | – | |
| New | Evolv Technologies Holdings, Inc. | $4,210,000 | – | 1,582,721 | – | 5.79% | – | |
| VOR | New | Vor Biopharma Inc. | $1,862,000 | – | 374,714 | – | 2.56% | – |
| DTIL | New | Precision BioSciences, Inc. | $1,798,000 | – | 1,123,913 | – | 2.48% | – |
| New | eFFECTOR Therapeutics, Inc. | $1,456,000 | – | 1,025,697 | – | 2.00% | – | |
| LABP | New | Landos Biopharma, Inc. | $1,174,000 | – | 1,612,764 | – | 1.62% | – |
| SELB | New | Selecta Biosciences, Inc. | $1,130,000 | – | 862,543 | – | 1.56% | – |
| GRPH | New | Graphite Bio | $1,117,000 | – | 406,308 | – | 1.54% | – |
| SPRO | New | Spero Therapeutics, Inc. | $185,000 | – | 249,070 | – | 0.26% | – |
| FIXX | New | Homology Medicines, Inc. | $126,000 | – | 64,000 | – | 0.17% | – |